Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wildflower Brands is a Canadian public company focused on plant-based wellness and cannabis-derived consumer health products. The company develops, designs, markets, and sells branded hemp-derived CBD and cannabis products, including topicals, soaps, tinctures, capsules, vaporizers, and bundled wellness kits. Its business appears centered on commercialized wellness products rather than a traditional drug-development pipeline, and it has operated in U.S. cannabis markets including Washington and California. Wildflower has also been associated with the City Cannabis retail business and broader cannabis branding activities. For biotech-style diligence, it should be viewed as a commercial cannabis wellness company rather than a therapeutics-focused biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wildflower Brands.